Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Shimada

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Druggable oncogene fusions in invasive mucinous lung adenocarcinomaTakashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, et al.
Molecular Cancer|September 1, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targetsKen Asada, Syuzo Kaneko, Ken Takasawa, et al.
Gynecologic Oncology|November 24, 2019
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patientsSou Hirose, Naoya Murakami, Kazuaki Takahashi, et al.
Nature Medicine|February 14, 2012
KIF5B-RET fusions in lung adenocarcinomaTakashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
Cancer Science|February 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast CancerRui Kitadai, Shu Yazaki, Aya Kuchiba, et al.
Nature Communications|August 10, 2016
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinomaKouya Shiraishi, Yukinori Okada, Atsushi Takahashi, et al.
NPJ Breast Cancer|November 29, 2025
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancerShu Yazaki, Rui Kitadai, Yukihide Momozawa, et al.
Ebiomedicine|May 22, 2025
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysisShu Yazaki, Megumi Hori, Hisaki Aiba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2025
Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinomaHourin Cho, Kouya Shiraishi, Kuniko Sunami, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Druggable oncogene fusions in invasive mucinous lung adenocarcinomaTakashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, et al.
Molecular Cancer|September 1, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targetsKen Asada, Syuzo Kaneko, Ken Takasawa, et al.
Gynecologic Oncology|November 24, 2019
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patientsSou Hirose, Naoya Murakami, Kazuaki Takahashi, et al.
Nature Medicine|February 14, 2012
KIF5B-RET fusions in lung adenocarcinomaTakashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
Cancer Science|February 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast CancerRui Kitadai, Shu Yazaki, Aya Kuchiba, et al.
Nature Communications|August 10, 2016
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinomaKouya Shiraishi, Yukinori Okada, Atsushi Takahashi, et al.
NPJ Breast Cancer|November 29, 2025
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancerShu Yazaki, Rui Kitadai, Yukihide Momozawa, et al.
Ebiomedicine|May 22, 2025
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysisShu Yazaki, Megumi Hori, Hisaki Aiba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2025
Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinomaHourin Cho, Kouya Shiraishi, Kuniko Sunami, et al.
Pageof 7